Annual Current Liabilities:
$47.87M+$21.24M(+79.74%)Summary
- As of today, VRDN annual current liabilities is $47.87 million, with the most recent change of +$21.24 million (+79.74%) on December 31, 2024.
- During the last 3 years, VRDN annual current liabilities has risen by +$34.24 million (+251.09%).
- VRDN annual current liabilities is now at all-time high.
Performance
VRDN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$52.59M+$18.86M(+55.91%)Summary
- As of today, VRDN quarterly current liabilities is $52.59 million, with the most recent change of +$18.86 million (+55.91%) on June 30, 2025.
- Over the past year, VRDN quarterly current liabilities has increased by +$15.82 million (+43.04%).
- VRDN quarterly current liabilities is now at all-time high.
Performance
VRDN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VRDN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +79.7% | +43.0% |
| 3Y3 Years | +251.1% | +145.9% |
| 5Y5 Years | +370.3% | +682.2% |
VRDN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +251.1% | at high | +126.2% |
| 5Y | 5-Year | at high | +370.3% | at high | +595.8% |
| All-Time | All-Time | at high | +2306.9% | at high | +2543.8% |
VRDN Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $52.59M(+55.9%) |
| Mar 2025 | - | $33.73M(-29.6%) |
| Dec 2024 | $47.87M(+79.7%) | $47.87M(+15.7%) |
| Sep 2024 | - | $41.36M(+12.5%) |
| Jun 2024 | - | $36.76M(+40.7%) |
| Mar 2024 | - | $26.13M(-1.9%) |
| Dec 2023 | $26.64M(-20.1%) | $26.64M(+14.6%) |
| Sep 2023 | - | $23.25M(-18.9%) |
| Jun 2023 | - | $28.66M(-3.1%) |
| Mar 2023 | - | $29.59M(-11.3%) |
| Dec 2022 | $33.35M(+144.6%) | $33.35M(+55.9%) |
| Jun 2022 | - | $21.39M(+48.7%) |
| Mar 2022 | - | $14.39M(+5.5%) |
| Dec 2021 | $13.64M(+27.7%) | $13.64M(-4.9%) |
| Sep 2021 | - | $14.34M(-14.8%) |
| Jun 2021 | - | $16.83M(+2.4%) |
| Mar 2021 | - | $16.44M(+54.0%) |
| Dec 2020 | $10.67M(+4.9%) | $10.67M(+41.2%) |
| Sep 2020 | - | $7.56M(+12.4%) |
| Jun 2020 | - | $6.72M(-22.4%) |
| Mar 2020 | - | $8.66M(-14.9%) |
| Dec 2019 | $10.18M | $10.18M(-2.0%) |
| Sep 2019 | - | $10.38M(+13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $9.15M(+33.4%) |
| Mar 2019 | - | $6.86M(+1.9%) |
| Dec 2018 | $6.73M(+72.8%) | $6.73M(-1.5%) |
| Sep 2018 | - | $6.83M(+59.5%) |
| Jun 2018 | - | $4.28M(+3.6%) |
| Mar 2018 | - | $4.14M(+6.2%) |
| Dec 2017 | $3.90M(-15.0%) | $3.90M(-40.4%) |
| Sep 2017 | - | $6.53M(-1.4%) |
| Jun 2017 | - | $6.63M(-8.9%) |
| Mar 2017 | - | $7.28M(+5.7%) |
| Dec 2016 | $4.58M(+85.8%) | $6.88M(+141.3%) |
| Sep 2016 | - | $2.85M(+9.9%) |
| Jun 2016 | - | $2.60M(+6.3%) |
| Mar 2016 | - | $2.44M(-1.0%) |
| Dec 2015 | $2.47M(+24.1%) | $2.47M(+16.7%) |
| Sep 2015 | - | $2.11M(+1.9%) |
| Jun 2015 | - | $2.08M(-16.8%) |
| Mar 2015 | - | $2.50M(+25.4%) |
| Dec 2014 | $1.99M(-92.7%) | $1.99M(-0.3%) |
| Sep 2014 | - | $2.00M(-6.7%) |
| Jun 2014 | - | $2.14M(-92.2%) |
| Dec 2013 | $27.30M(+15.7%) | $27.30M(+15.7%) |
| Dec 2012 | $23.60M | - |
| Dec 2012 | - | $23.60M |
FAQ
- What is Viridian Therapeutics, Inc. annual current liabilities?
- What is the all-time high annual current liabilities for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual current liabilities year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly current liabilities?
- What is the all-time high quarterly current liabilities for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly current liabilities year-on-year change?
What is Viridian Therapeutics, Inc. annual current liabilities?
The current annual current liabilities of VRDN is $47.87M
What is the all-time high annual current liabilities for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual current liabilities is $47.87M
What is Viridian Therapeutics, Inc. annual current liabilities year-on-year change?
Over the past year, VRDN annual current liabilities has changed by +$21.24M (+79.74%)
What is Viridian Therapeutics, Inc. quarterly current liabilities?
The current quarterly current liabilities of VRDN is $52.59M
What is the all-time high quarterly current liabilities for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly current liabilities is $52.59M
What is Viridian Therapeutics, Inc. quarterly current liabilities year-on-year change?
Over the past year, VRDN quarterly current liabilities has changed by +$15.82M (+43.04%)